<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.1.189">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>talks - Sarcopenia Literature</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1.6em;
  vertical-align: middle;
}
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit"
  }
}</script>


<link rel="stylesheet" href="styles.css">
</head>

<body class="nav-fixed">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
    <nav class="navbar navbar-expand-lg navbar-dark ">
      <div class="navbar-container container-fluid">
      <div class="navbar-brand-container">
    <a class="navbar-brand" href="./index.html">
    <span class="navbar-title">talks</span>
    </a>
  </div>
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" aria-expanded="false" aria-label="Toggle navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
  <span class="navbar-toggler-icon"></span>
</button>
          <div class="collapse navbar-collapse" id="navbarCollapse">
            <ul class="navbar-nav navbar-nav-scroll me-auto">
  <li class="nav-item">
    <a class="nav-link" href="./index.html">Home</a>
  </li>  
  <li class="dropdown-header">
 about.qmd</li>
</ul>
              <div id="quarto-search" class="" title="Search"></div>
          </div> <!-- /navcollapse -->
      </div> <!-- /container-fluid -->
    </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">On this page</h2>
   
  <ul>
  <li><a href="#body-composition-measurement-by-ct" id="toc-body-composition-measurement-by-ct" class="nav-link active" data-scroll-target="#body-composition-measurement-by-ct">Body Composition Measurement by CT</a>
  <ul class="collapse">
  <li><a href="#lenchik-papers" id="toc-lenchik-papers" class="nav-link" data-scroll-target="#lenchik-papers">Lenchik Papers</a></li>
  </ul></li>
  <li><a href="#frailty-and-chemotherapy" id="toc-frailty-and-chemotherapy" class="nav-link" data-scroll-target="#frailty-and-chemotherapy">Frailty and Chemotherapy</a></li>
  <li><a href="#comrehensive-geriatric-assessment" id="toc-comrehensive-geriatric-assessment" class="nav-link" data-scroll-target="#comrehensive-geriatric-assessment">Comrehensive Geriatric Assessment</a>
  <ul class="collapse">
  <li><a href="#geriatric-8-screening" id="toc-geriatric-8-screening" class="nav-link" data-scroll-target="#geriatric-8-screening">Geriatric-8 Screening</a></li>
  </ul></li>
  <li><a href="#colorectal-cancer" id="toc-colorectal-cancer" class="nav-link" data-scroll-target="#colorectal-cancer">Colorectal Cancer</a></li>
  <li><a href="#undertreatment-of-cancer-in-the-elderly" id="toc-undertreatment-of-cancer-in-the-elderly" class="nav-link" data-scroll-target="#undertreatment-of-cancer-in-the-elderly">Undertreatment of cancer in the elderly</a></li>
  <li><a href="#gastric-cancer" id="toc-gastric-cancer" class="nav-link" data-scroll-target="#gastric-cancer">Gastric Cancer</a></li>
  <li><a href="#resources" id="toc-resources" class="nav-link" data-scroll-target="#resources">Resources</a></li>
  <li><a href="#bmi-and-survival-in-stage-iv-cancer" id="toc-bmi-and-survival-in-stage-iv-cancer" class="nav-link" data-scroll-target="#bmi-and-survival-in-stage-iv-cancer">BMI and survival in stage IV cancer</a></li>
  <li><a href="#performance-status-and-chemotherapy" id="toc-performance-status-and-chemotherapy" class="nav-link" data-scroll-target="#performance-status-and-chemotherapy">Performance status and chemotherapy</a></li>
  <li><a href="#age-and-receipt-of-chemotherapy" id="toc-age-and-receipt-of-chemotherapy" class="nav-link" data-scroll-target="#age-and-receipt-of-chemotherapy">Age and receipt of chemotherapy</a></li>
  <li><a href="#platelet-neutrophil-leukocytes" id="toc-platelet-neutrophil-leukocytes" class="nav-link" data-scroll-target="#platelet-neutrophil-leukocytes">Platelet Neutrophil Leukocytes</a></li>
  <li><a href="#immunotherapy-in-frail-patients" id="toc-immunotherapy-in-frail-patients" class="nav-link" data-scroll-target="#immunotherapy-in-frail-patients">Immunotherapy in Frail patients</a></li>
  <li><a href="#reporting" id="toc-reporting" class="nav-link" data-scroll-target="#reporting">Reporting</a></li>
  <li><a href="#mortality-after-gi-cancer-surgery" id="toc-mortality-after-gi-cancer-surgery" class="nav-link" data-scroll-target="#mortality-after-gi-cancer-surgery">Mortality after GI Cancer Surgery</a></li>
  <li><a href="#palliative-care-consultations" id="toc-palliative-care-consultations" class="nav-link" data-scroll-target="#palliative-care-consultations">Palliative Care consultations</a></li>
  <li><a href="#enteral-nutrition-in-cancer-patients" id="toc-enteral-nutrition-in-cancer-patients" class="nav-link" data-scroll-target="#enteral-nutrition-in-cancer-patients">Enteral nutrition in cancer patients</a></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title">Sarcopenia Literature</h1>
</div>



<div class="quarto-title-meta">

    
    
  </div>
  

</header>

<section id="body-composition-measurement-by-ct" class="level1">
<h1>Body Composition Measurement by CT</h1>
<section id="lenchik-papers" class="level2">
<h2 class="anchored" data-anchor-id="lenchik-papers">Lenchik Papers</h2>
<p>IV Contrast Tube current - <span class="citation" data-cites="fuchs2455">(<a href="#ref-fuchs2455" role="doc-biblioref">Fuchs et al. 2018</a>)</span> Slice Thickness <span class="citation" data-cites="morsbach50">(<a href="#ref-morsbach50" role="doc-biblioref">Morsbach et al. 2019</a>)</span> Contrasst challenges <span class="citation" data-cites="bae32">(<a href="#ref-bae32" role="doc-biblioref">Bae 2010</a>)</span> Muscle L4 contrast <span class="citation" data-cites="boutin1046">(<a href="#ref-boutin1046" role="doc-biblioref">Boutin et al. 2016</a>)</span> IV contrast and muscle size <span class="citation" data-cites="vanderwerf366">(<a href="#ref-vanderwerf366" role="doc-biblioref">van der Werf et al. 2018</a>)</span> <span class="citation" data-cites="vanvugt1707">(<a href="#ref-vanvugt1707" role="doc-biblioref">van Vugt et al. 2018</a>)</span> kV<span class="citation" data-cites="morsbach9">(<a href="#ref-morsbach9" role="doc-biblioref"><strong>morsbach9?</strong></a>)</span></p>
<p>ICC 24/35/42 <span class="citation" data-cites="fuchs2455">(<a href="#ref-fuchs2455" role="doc-biblioref">Fuchs et al. 2018</a>)</span> <span class="citation" data-cites="vanderwerf366">(<a href="#ref-vanderwerf366" role="doc-biblioref">van der Werf et al. 2018</a>)</span> <span class="citation" data-cites="barnard1686">(<a href="#ref-barnard1686" role="doc-biblioref">Barnard et al. 2019</a>)</span> <span class="citation" data-cites="perthen142">(<a href="#ref-perthen142" role="doc-biblioref">Perthen et al. 2018</a>)</span></p>
<p>Machine learning 43-46 <span class="citation" data-cites="jang360">(<a href="#ref-jang360" role="doc-biblioref">Jang et al. 2019</a>)</span> ML methods from Lung Cancer Screening Trial. CNN with U-NET. Left paraspinous muscle at T12. CSA and MA.&nbsp; Dice scores of 0.94 r^2 0.86 for CSA and 0.2 for MA. Manual segmentation with Mimics. In the input pipeline, the ground truth image was extracted from the Mimics-exportedDigital Imaging and Communications in Medicine (DICOM) using a simple R [69] procedure, with the oro.nifti [70] library providing input and output functionality. The mask was cleaned using a custom Python script built with NiBabel [71] for I/O, SciPy [72] for spatial calculations, and NumPy [73] for general numeric operations. Additional preparation of ground truth data used the ImageMath and fslstats programs of the Advanced Normalization Tools [74] and FMRIB Software Library [75] respectively. Preparation of the 3-channel input images used scikit-image’s [76] rescale_intensity and equalize_adapthist functions for clipping and equalization. Overlap measures were implemented as functions of the confusion matrix provided by scikit-learn’s [77] confusion_matrix function and assembled into easily-analyzed tabular representations using Pandas [78]. Subsequent correlation analyses of the muscle CSA and MA were performed with R’s cor.test function. Algorithm can’t select L3 <a href="http://www.jstatsoft.org/v44/i06/">Working with DICOM and IIfTI in R</a> Snakemake<span class="citation" data-cites="koster2520">(<a href="#ref-koster2520" role="doc-biblioref">Köster and Rahmann 2012</a>)</span></p>
<p>NLST and mortality <span class="citation" data-cites="lenchik277">(<a href="#ref-lenchik277" role="doc-biblioref">Lenchik et al. 2021</a>)</span> Increased SMA and SMD associated with longer survival</p>
<p><span class="citation" data-cites="barnard1686">(<a href="#ref-barnard1686" role="doc-biblioref">Barnard et al. 2019</a>)</span> <span class="citation" data-cites="lenchik1695">(<a href="#ref-lenchik1695" role="doc-biblioref">Lenchik et al. 2019</a>)</span></p>
<p><span class="citation" data-cites="kullberg10425">(<a href="#ref-kullberg10425" role="doc-biblioref">Kullberg et al. 2017</a>)</span></p>
<p>Sarcopenia methods - varies 19/92 <span class="citation" data-cites="amini1671">(<a href="#ref-amini1671" role="doc-biblioref">Amini et al. 2019</a>)</span> Review of challenges in methods inconsistency <span class="citation" data-cites="hopkins1381">(<a href="#ref-hopkins1381" role="doc-biblioref">Hopkins et al. 2018</a>)</span></p>
<p>myosteatosis adds value 93 <span class="citation" data-cites="martin227">(<a href="#ref-martin227" role="doc-biblioref">Martin et al. 2020</a>)</span></p>
<p>Fully automated tools 94-96 <span class="citation" data-cites="graffy20190327">(<a href="#ref-graffy20190327" role="doc-biblioref">Graffy et al. 2019</a>)</span> <span class="citation" data-cites="burns311">(<a href="#ref-burns311" role="doc-biblioref">Burns et al. 2020</a>)</span> <span class="citation" data-cites="hemke387">(<a href="#ref-hemke387" role="doc-biblioref">Hemke et al. 2020</a>)</span></p>
<p>Machine learning <span class="citation" data-cites="lee487">(<a href="#ref-lee487" role="doc-biblioref">Lee et al. 2017</a>)</span> <span class="citation" data-cites="popuri512">(<a href="#ref-popuri512" role="doc-biblioref">Popuri et al. 2016</a>)</span></p>
<p>L3 slice selection <span class="citation" data-cites="islame363">(<a href="#ref-islame363" role="doc-biblioref">Islam et al. 2022</a>)</span></p>
<p>Jack et al <span class="citation" data-cites="jack1313a">(<a href="#ref-jack1313a" role="doc-biblioref">Jack et al. 2014</a>)</span> studies VO2max before and after neoadjuvant chemoradiation prior to esophagectomy. Patients with lower baseline VO2max prior to surgery had lower 1-year survival after esophagectomy</p>
</section>
</section>
<section id="frailty-and-chemotherapy" class="level1">
<h1>Frailty and Chemotherapy</h1>
<p>Chemotherapy in frail patients:</p>
<p>Choosing Wisely <span class="citation" data-cites="schnipper10">(<a href="#ref-schnipper10" role="doc-biblioref">Schnipper et al., n.d.</a>)</span></p>
<p>ASCO statement <span class="citation" data-cites="hurria3826">(<a href="#ref-hurria3826" role="doc-biblioref">Hurria et al. 2015</a>)</span></p>
<p>Cancer patients in the UK have worse survival likely due to undertreatment after age 65 - editorial <span class="citation" data-cites="chanda">(<a href="#ref-chanda" role="doc-biblioref"><strong>chanda?</strong></a>)</span></p>
</section>
<section id="comrehensive-geriatric-assessment" class="level1">
<h1>Comrehensive Geriatric Assessment</h1>
<p>CGA recommended by ASCO <span class="citation" data-cites="mohile2326">(<a href="#ref-mohile2326" role="doc-biblioref">Mohile et al. 2018</a>)</span> buy screening is resource-intensive</p>
<ul>
<li><p>Instrumental ADLs</p></li>
<li><p>Assessment of comorbidities</p></li>
<li><p>Falls</p></li>
<li><p>Depression - Geriatic Depression Scale, Mini-Cog, Blessed Oreientati-Memory-Concentration</p></li>
<li><p>Nutrition-</p></li>
<li><p>Measures of chemotherapy toxicity:</p>
<ul>
<li><p>CRASH = Chemotherapy Risk Assessment Scale for High-Age Patients</p></li>
<li><p>CARG (Cancer and Aging Research Group)</p></li>
</ul></li>
<li><p>Mortality Estimates -</p>
<ul>
<li><p>Geriatric-8</p></li>
<li><p>Vulnerable Elders Survey-13</p></li>
<li><p>Non-Cancer Mortality - ePrognosis (life expectancy &gt;4years)</p></li>
</ul></li>
</ul>
<p>CGA - <span class="citation" data-cites="extermann1824">(<a href="#ref-extermann1824" role="doc-biblioref">Extermann and Hurria 2007</a>)</span></p>
<p><span class="citation" data-cites="extermann241">(<a href="#ref-extermann241" role="doc-biblioref">Extermann et al. 2005</a>)</span></p>
<p>Randomized trial of CGA intervention in colorectal cancer treatment in Sweden. <span class="citation" data-cites="Normann948">(<a href="#ref-Normann948" role="doc-biblioref"><strong>Normann948?</strong></a>)</span>. Trial will utilize CFS-9 score (Clinical Frailty Score-9). (In the US - median age of dx for colon cancer is 66 in men and 69 in women). Median age has shifted from median age of 72 in the early 2000s to 66 in 2020 ( Ries LAG, Eisner MP, Kosary CL, et al., eds.&nbsp;SEER Cancer Statistics Review, 1973-1999. Bethesda, MD: National Cancer Institute; 2002.)</p>
<p>CGA appears to add information to performance status alone (L. Repetto, L. Fratino, R. A. Audisio et al., "Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study," <em>Journal of Clinical Oncology</em>, vol.&nbsp;20, no. 2, pp.&nbsp;494–502, 2002.)</p>
<p>CGA affects cancer treatment in 50% (M. T. E. Puts, J. Hardt, J. Monette, V. Girre, E. Springall, and S. M. H. Alibhai, "Use of geriatric assessment for older adults in the oncology setting: a systematic review," <em>Journal of the National Cancer Institute</em>, vol.&nbsp;104, no. 15, pp.&nbsp;1133–1163, 2012</p>
<p>CARG - superior to KPS in predicting chemotherapy toxicity (A. Hurria, K. Togawa, S. G. Mohile et al., "Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study," <em>Journal of Clinical Oncology</em>, vol.&nbsp;29, no. 25, pp.&nbsp;3457–3465, 2011.)</p>
<p>CRASH (M. Extermann, I. Boler, R. R. Reich et al., "Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score," <em>Cancer</em>, vol.&nbsp;118, no. 13, pp.&nbsp;3377–3386, 2012)</p>
<p>Exercise behavior in METS (E. Ruden, D. A. Reardon, A. D. Coan et al., "Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma," <em>Journal of Clinical Oncology</em>, vol.&nbsp;29, no. 21, pp.&nbsp;2918–2923, 2011.) <span class="citation" data-cites="ruden2918">(<a href="#ref-ruden2918" role="doc-biblioref">Ruden et al. 2011</a>)</span> used Godin Leisure-Time Exercise Questionare</p>
<p>Godin questionnaire: Godin G, Shephard RJ: A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 10:141-146, 1985</p>
<p>6MWT Gibbons WJ, Fruchter N, Sloan S, et al: Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil 21:87-93, 2001</p>
<section id="geriatric-8-screening" class="level2">
<h2 class="anchored" data-anchor-id="geriatric-8-screening">Geriatric-8 Screening</h2>
<p>Bellera CA, Rainfray M, Mathoulin‐Pelissier S, et al.&nbsp;Screening older cancer patients: first evaluation of the G‐8 geriatric screening tool. Ann Oncol. 2012;23:2166‐2172.</p>
<p>Stokoe JM, Pearce J, Sinha R, Ring A. G8 and VES‐13 scores predict chemotherapy toxicity in older patients with cancer. J Geriatr Oncol. 2012;3(suppl 1):S81.</p>
</section>
</section>
<section id="colorectal-cancer" class="level1">
<h1>Colorectal Cancer</h1>
<p>Colorectal cancer. Estimated cases in US: 148,000 cases per year, of whom 80,000 are over age 65</p>
<p>NCDB of colon cancer: less adherence to treatment guidelines in elderly patients <span class="citation" data-cites="chen3395">(<a href="#ref-chen3395" role="doc-biblioref">Chen et al. 2020</a>)</span></p>
<p>Stage IV colon cancer over age 75: Equivalent response rates in patients older than 75 and younger. <span class="citation" data-cites="rosati578">(<a href="#ref-rosati578" role="doc-biblioref">Rosati et al. 2019</a>)</span></p>
<p>Meta-analysis of 13 trials of palliative chemotherapy in advanced colorectal cancer showed that chemotherapy for colorectal cancer improves survival by 3.7months and results in improvement of survival of 16% at both 6 and 12 months. ECOG 3/4 only comprise &lt;10% of the total sample of trial participants.<span class="citation" data-cites="simmonds531">(<a href="#ref-simmonds531" role="doc-biblioref">Simmonds 2000</a>)</span></p>
<p>PS2 patients with stage IV CRC have survival less than half that of those with PS of 0 at presentation <span class="citation" data-cites="lavin1536">(<a href="#ref-lavin1536" role="doc-biblioref">Lavin et al. 1980</a>)</span> <span class="citation" data-cites="kemeny786">(<a href="#ref-kemeny786" role="doc-biblioref">Kemeny and Braun 1983</a>)</span></p>
<p>ECOG2 patients receiving first-line chemotherapy for CRC had 12% 60-day morality <span class="citation" data-cites="sargent1948">(<a href="#ref-sargent1948" role="doc-biblioref">Sargent et al. 2009</a>)</span></p>
<p>Kohorana Score for CRC early death: (primary site, baseline hemoglobin, leukocyte and platelet counts, BMI) <span class="citation" data-cites="khorana4902">(<a href="#ref-khorana4902" role="doc-biblioref"><strong>khorana4902?</strong></a>)</span></p>
<p>Stage IV CRC prognostic model: [chibaudel1228] = f(performance status, LDH,number of metastatic sites). Serum LDH most prognostic factor, followed by PS</p>
<p>Kohne model: PS, WBC, ALP, number of metastatic sites <span class="citation" data-cites="kohne308">(<a href="#ref-kohne308" role="doc-biblioref">Köhne et al. 2002</a>)</span></p>
</section>
<section id="undertreatment-of-cancer-in-the-elderly" class="level1">
<h1>Undertreatment of cancer in the elderly</h1>
<ol type="1">
<li>Foster JA, Salinas GD, Mansell D, Williamson JC, Casebeer LL. How does older age influence oncologists’ cancer management? Oncologist. 2010;15(6):584–92. <a href="https://doi.org/10.1634/theoncologist.2009-0198" class="uri">https://doi.org/10.1634/theoncologist.2009-0198</a> . - <a href="https://doi.org/10.1634/theoncologist.2009-0198">DOI</a>- <a href="https://pubmed.ncbi.nlm.nih.gov/20495217/">PubMed</a>- <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/3227998/">PMC</a></li>
</ol>
<p>Age and comorbidity affect recommendations for chemotherapy in stage III colon cancer - more variability of recommendation for older patients<span class="citation" data-cites="keating2532">(<a href="#ref-keating2532" role="doc-biblioref">Keating et al. 2008</a>)</span></p>
</section>
<section id="gastric-cancer" class="level1">
<h1>Gastric Cancer</h1>
<p>Non-cancer prognosis after gastrectomy in Japan: Male sex, neutrophil-lymphocyte ratio, skeletal muscel index <span class="citation" data-cites="iida753">(<a href="#ref-iida753" role="doc-biblioref">Iida et al. 2022</a>)</span></p>
</section>
<section id="resources" class="level1">
<h1>Resources</h1>
<p>Dalane Kitzman - https://www.wakehealth.edu/providers/k/dalane-w-kitzman dkitzman@wakehealth.edu</p>
</section>
<section id="bmi-and-survival-in-stage-iv-cancer" class="level1">
<h1>BMI and survival in stage IV cancer</h1>
<p>Low BMI may be associated with high cancer-specific mortality (Renfro LA, Loupakis F, Adams RA. et al.&nbsp;Body mass index is prognostic in metastatic colorectal cancer: Pooled analysis of patients from first-line clinical trials in the ARCAD database. J Clin Oncol. 2016;34(2):144–150. 10.1200/JCO.2015.61.6441) High BMI may be an indicator of co-morbidities and may be associated with high non-cancer mortality ( Lee J, Meyerhardt JA, Giovannucci E, Jeon JY.. Association between body mass index and prognosis of colorectal cancer: A meta-analysis of prospective cohort studies. PLoS One. 2015;10:e0120706.) Visceral adiposity is associated with higher mortality in patients undergoing adjuvant chemotherapy (Lee CS, Murphy DJ, McMahon C, et al.&nbsp;Visceral adiposity is a risk factor for poor prognosis in colorectal cancer patients receiving adjuvant chemotherapy. J Gastrointest Cancer. 2015;46(3):243–250. 10.1007/s12029-015-9709-0)</p>
</section>
<section id="performance-status-and-chemotherapy" class="level1">
<h1>Performance status and chemotherapy</h1>
<p>Clinical trials typically enroll less than 10% of patients with PS of 2</p>
<p>ECOG may be less accurate in the low end of the scale (E. Verger, M. Salamero, and C. Conill, “Can Karnofsky performance status be transformed to the Eastern Cooperative Oncology Group scoring scale and vice versa?” European Journal of Cancer A, vol.&nbsp;28, no. 8-9, pp.&nbsp;1328–1330, 1992.)</p>
<p>Low inter-observer agreement (J. Myers, K. Gardiner, K. Harris et al., “Evaluating correlation and interrater reliability for four performance scales in the palliative care setting,” Journal of Pain and Symptom Management, vol.&nbsp;39, no. 2, pp.&nbsp;250–258, 2010.)</p>
<p>Poor inter-observer agreement of ECOG, with oncolgist and nurses recording higher values than patients (M. Ando, Y. Ando, Y. Hasegawa et al., “Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer,” British Journal of Cancer, vol.&nbsp;85, no. 11, pp.&nbsp;1634–1639, 2001)</p>
<p>Interobserver agreement between patient and oncologist 50% in lung cancer (S. P. Blagden, S. C. Charman, L. D. Sharples, L. R. A. Magee, and D. Gilligan, “Performance status score: do patients and their oncologists agree?” British Journal of Cancer, vol.&nbsp;89, no. 6, pp.&nbsp;1022–1027, 2003.)</p>
<p>M.M. Oken, R.H. Creech, D.C. Tormey, et al. Toxicity and response criteria of the eastern cooperative oncology group Am. J. Clin. Oncol., 5 (1982), pp.&nbsp;649-655</p>
<p>R. Chow, N. Chiu, E. Bruera, et al. Inter-rater reliability in performance status assessment among health care professionals: a systematic review Ann. Palliat. Med., 5 (2016), pp.&nbsp;83-92</p>
<p>All-cause mortality risk prediction in geriatric oncology <span class="citation" data-cites="perez-de-acha1377">(<a href="#ref-perez-de-acha1377" role="doc-biblioref">Perez-de-Acha, Pilleron, and Soto-Perez-de-Celis 2022</a>)</span> Predicting life expectancy in older adults with cancer <span class="citation" data-cites="verduzco-aguirre68">(<a href="#ref-verduzco-aguirre68" role="doc-biblioref">Verduzco-Aguirre et al. 2019</a>)</span></p>
<p>Functional vs chronological age<span class="citation" data-cites="soto-perez-de-celise305">(<a href="#ref-soto-perez-de-celise305" role="doc-biblioref">Soto-Perez-de-Celis et al. 2018</a>)</span></p>
</section>
<section id="age-and-receipt-of-chemotherapy" class="level1">
<h1>Age and receipt of chemotherapy</h1>
<p>H. K. Sanoff, W. R. Carpenter, T. Sturmer et al.&nbsp;et al., “Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years,” Journal of Clinical Oncology, vol.&nbsp;30, no. 21, pp.&nbsp;2624–2634, 2012 D. Schrag, L. D. Cramer, P. B. Bach, and C. B. Begg, “Age and adjuvant chemotherapy use after surgery for stage III colon cancer,” Journal of the National Cancer Institute, vol.&nbsp;93, no. 11, pp.&nbsp;850–857, 2001.</p>
<p>Older patients do derive benefit from chemotherapy H. B. Muss, S. Woolf, D. Berry et al., “Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer,” The Journal of the American Medical Association, vol.&nbsp;293, no. 9, pp.&nbsp;1073–1081, 2005.</p>
<p>Older adults &gt;70 are less likely to be enrolled in 2nd line trials for</p>
</section>
<section id="platelet-neutrophil-leukocytes" class="level1">
<h1>Platelet Neutrophil Leukocytes</h1>
<p><span class="citation" data-cites="mercier478">(<a href="#ref-mercier478" role="doc-biblioref"><strong>mercier478?</strong></a>})</span></p>
<p>Tan D, Fu Y, Su Q, et al.&nbsp;Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2016;95:e3837.</p>
<p>Li MX, Liu XM, Zhang XF, et al.&nbsp;Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis. Int J Cancer 2014;134:2403-13.</p>
</section>
<section id="immunotherapy-in-frail-patients" class="level1">
<h1>Immunotherapy in Frail patients</h1>
<p>Creighton: <span class="citation" data-cites="krishnane175">(<a href="#ref-krishnane175" role="doc-biblioref">Krishnan et al. 2022</a>)</span> 257 patients with advanced solid tumor receiving immune checkpoint inhibitors. 182 were ECOG 0-1 and 75 were ECOG &gt;=2. Median overall survival was 12.6 months for the ECOG PS 0-1 group compared with 3.1 months for the ECOG PS ≥ 2 group (P &lt; .001). The overall response rate for patients with ECOG PS 0-1 was 23% compared with 8% for those with poor PS (P = .005). Patients with poor PS treated with ICI had similar hospice referral rates (67% for ECOG PS ≥ 2 v 61.9% for ECOG PS 0-1, P = .50) but were more likely to have in-hospital death as compared with the good PS group (28.6% v 15.1%, P = .035).</p>
<p>India: <span class="citation" data-cites="kapoore25115">(<a href="#ref-kapoore25115" role="doc-biblioref">Kapoor et al. 2021</a>)</span> 155 patients receiving ICIs. ECOG 0-1 had median survival 9.1 months vs 2.9months in ECOG 2-4. Median OS for ECOG2 was 3.7months vs 1.8 months with ECOG 3-4</p>
<p>Meta-analysis of IC trials: No difference in benefit for ECOG 0 vs ECOG &gt;=1 <span class="citation" data-cites="yange2012534">(<a href="#ref-yange2012534" role="doc-biblioref">Yang et al. 2020</a>)</span></p>
<p>Melanoma PS2-3 treated with ICI had median survival of 18 months vs 19.5 months for ECOG 0-1 <span class="citation" data-cites="wong385">(<a href="#ref-wong385" role="doc-biblioref">Wong et al. 2017</a>)</span></p>
<p>Lung cancer with ECOG 2+ had worse prognosis than ECOG 0-1 in NSCLC treated with pembro <span class="citation" data-cites="sehgale2037120">(<a href="#ref-sehgale2037120" role="doc-biblioref"><strong>sehgale2037120?</strong></a>)</span></p>
<p>NSCLC treated with ICI: shorter survival in ECOG 2+ compared with PS 0-1 <span class="citation" data-cites="petrillo2288">(<a href="#ref-petrillo2288" role="doc-biblioref">Petrillo et al. 2020</a>)</span></p>
<p>NSCLC meta-analysis of ECOG 2: <span class="citation" data-cites="tomasik97">(<a href="#ref-tomasik97" role="doc-biblioref"><strong>tomasik97?</strong></a>)</span> Patients with impaired PS are twice as likely to achieve a response compared with ECOG 0-1</p>
<p>France <span class="citation" data-cites="facchinetti155">(<a href="#ref-facchinetti155" role="doc-biblioref">Facchinetti et al. 2020</a>)</span> 153 patients ECOG 2. Patients who were ECOG 2 due to comorbidities (n=41) had much better prognosis (median survival 11.8 vs 2.8 months) than those ECOG 2 due to disease burden(n=112)</p>
<p>Checkpoint inhibitor dose in the last 30 days of life associated with poor PS and dying in hospital <span class="citation" data-cites="glish179">(<a href="#ref-glish179" role="doc-biblioref"><strong>glish179?</strong></a>)</span></p>
</section>
<section id="reporting" class="level1">
<h1>Reporting</h1>
<p>Benchimol EI, Smeeth L, Guttmann A, et al.&nbsp;The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. https://doi.org/10.1371/journal.pmed.1001885 . - DOI - PubMed - PMC</p>
</section>
<section id="mortality-after-gi-cancer-surgery" class="level1">
<h1>Mortality after GI Cancer Surgery</h1>
<p>Eindhoven cancer registry. Esohpagectomy 90=day mortality 7.1% for &lt;65 years, 8.7% for 65-74 years, and 15.4% for 75+</p>
<p>Mortality should be reported at 90 days Mayo SC, Shore AD, Nathan H, Edil BH, Hirose K, Anders RA, et al.&nbsp;Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford). 2011;13:473–82 Venkat R, Puhan MA, Schulick RD, Cameron JL, Eckhauser FE, Choti MA, et al.&nbsp;Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system. Arch Surg. 2011;146:1277–84 Bryant AS, Rudemiller K, Cerfolio RJ. The 30- versus 90-day operative mortality after pulmonary resection. Ann Thorac Surg. 2010;89: 1717–22; discussion 1722–3</p>
<p>Preoperative Assessment of Cancer in the Elderly (PACE): Audisio RA, Pope D, Ramesh HS, Gennari R, van Leeuwen BL, West C, et al.&nbsp;Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol. 2008;65:156–63 Heriot AG, Tekkis PP, Smith JJ, Cohen CR, Montgomery A, Audisio RA, et al.&nbsp;Prediction of postoperative mortality in elderly patients with colorectal cancer. Dis Colon Rectum. 2006;49:816–24 Pope D, Ramesh H, Gennari R, Corsini G, Maffezzini M, Hoekstra HJ, et al.&nbsp;Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol. 2006;15:189–97</p>
<p>Prognostic scales for cancer: France: <span class="citation" data-cites="canout-poitrine2236">(<a href="#ref-canout-poitrine2236" role="doc-biblioref"><strong>canout-poitrine2236?</strong></a>)</span> 510 patients with cancer evaluated with multiple prognostic scales including CCI and Elixhauser. Only Cumulative Illness Rating Scale for Geriatics (CIR-G) was predictive of one-year mortality.</p>
</section>
<section id="palliative-care-consultations" class="level1">
<h1>Palliative Care consultations</h1>
<p>VA System: <span class="citation" data-cites="sullivan1702">(<a href="#ref-sullivan1702" role="doc-biblioref"><strong>sullivan1702?</strong></a>)</span> Lung Cancer - palliative care consultation 31-365 days after dx led to increased survival</p>
</section>
<section id="enteral-nutrition-in-cancer-patients" class="level1">
<h1>Enteral nutrition in cancer patients</h1>
<p>In 347 stage IV gastric cancer patients at high nutrition risk and receiving palliative CT, nutritional support was associated with a survival benefit 39.Qiu M, ZhouYX, Jin Y, Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy. Support Care Cancer. 2015: 23; 1933. -9 Esophageal cancer patients RCT enteral therapy vs oral nutrition <span class="citation" data-cites="lyu839516">(<a href="#ref-lyu839516" role="doc-biblioref">Lyu et al. 2022</a>)</span></p>



</section>

<div id="quarto-appendix" class="default"><section class="quarto-appendix-contents" role="doc-bibliography"><h2 class="anchored quarto-appendix-heading">References</h2><div id="refs" class="references csl-bib-body hanging-indent" role="doc-bibliography">
<div id="ref-amini1671" class="csl-entry" role="doc-biblioentry">
Amini, Behrang, Sean P. Boyle, Robert D. Boutin, and Leon Lenchik. 2019. <span>“Approaches to <span>Assessment</span> of <span>Muscle Mass</span> and <span>Myosteatosis</span> on <span>Computed Tomography</span>: <span>A Systematic Review</span>.”</span> <em>The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences</em> 74 (10): 1671–78. <a href="https://doi.org/10.1093/gerona/glz034">https://doi.org/10.1093/gerona/glz034</a>.
</div>
<div id="ref-bae32" class="csl-entry" role="doc-biblioentry">
Bae, Kyongtae T. 2010. <span>“Intravenous Contrast Medium Administration and Scan Timing at <span>CT</span>: Considerations and Approaches.”</span> <em>Radiology</em> 256 (1): 32–61. <a href="https://doi.org/10.1148/radiol.10090908">https://doi.org/10.1148/radiol.10090908</a>.
</div>
<div id="ref-barnard1686" class="csl-entry" role="doc-biblioentry">
Barnard, Ryan, Josh Tan, Brandon Roller, Caroline Chiles, Ashley A. Weaver, Robert D. Boutin, Stephen B. Kritchevsky, and Leon Lenchik. 2019. <span>“Machine <span>Learning</span> for <span>Automatic Paraspinous Muscle Area</span> and <span>Attenuation Measures</span> on <span>Low-Dose Chest CT Scans</span>.”</span> <em>Academic Radiology</em> 26 (12): 1686–94. <a href="https://doi.org/10.1016/j.acra.2019.06.017">https://doi.org/10.1016/j.acra.2019.06.017</a>.
</div>
<div id="ref-boutin1046" class="csl-entry" role="doc-biblioentry">
Boutin, Robert D., Justin M. Kaptuch, Cyrus P. Bateni, James S. Chalfant, and Lawrence Yao. 2016. <span>“Influence of <span>IV Contrast Administration</span> on <span>CT Measures</span> of <span>Muscle</span> and <span>Bone Attenuation</span>: <span>Implications</span> for <span>Sarcopenia</span> and <span>Osteoporosis Evaluation</span>.”</span> <em>AJR. American Journal of Roentgenology</em> 207 (5): 1046–54. <a href="https://doi.org/10.2214/AJR.16.16387">https://doi.org/10.2214/AJR.16.16387</a>.
</div>
<div id="ref-burns311" class="csl-entry" role="doc-biblioentry">
Burns, Joseph E., Jianhua Yao, Didier Chalhoub, Joseph J. Chen, and Ronald M. Summers. 2020. <span>“A <span>Machine Learning Algorithm</span> to <span>Estimate Sarcopenia</span> on <span>Abdominal CT</span>.”</span> <em>Academic Radiology</em> 27 (3): 311–20. <a href="https://doi.org/10.1016/j.acra.2019.03.011">https://doi.org/10.1016/j.acra.2019.03.011</a>.
</div>
<div id="ref-chen3395" class="csl-entry" role="doc-biblioentry">
Chen, Fa, Fei Wang, Christina E. Bailey, Harvey J. Murff, Jordan D. Berlin, Xiao-Ou Shu, and Wei Zheng. 2020. <span>“<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642646">Evaluation of Determinants for Age Disparities in the Survival Improvement of Colon Cancer: Results from a Cohort of More Than 486,000 Patients in the <span>United States</span></a>.”</span> <em>American Journal of Cancer Research</em> 10 (10): 3395–405.
</div>
<div id="ref-extermann241" class="csl-entry" role="doc-biblioentry">
Extermann, Martine, Matti Aapro, Roberto Bernabei, Harvey Jay Cohen, Jean-Pierre Droz, Stuart Lichtman, Vincent Mor, et al. 2005. <span>“Use of Comprehensive Geriatric Assessment in Older Cancer Patients: Recommendations from the Task Force on <span>CGA</span> of the <span>International Society</span> of <span>Geriatric Oncology</span> (<span>SIOG</span>).”</span> <em>Critical Reviews in Oncology/Hematology</em> 55 (3): 241–52. <a href="https://doi.org/10.1016/j.critrevonc.2005.06.003">https://doi.org/10.1016/j.critrevonc.2005.06.003</a>.
</div>
<div id="ref-extermann1824" class="csl-entry" role="doc-biblioentry">
Extermann, Martine, and Arti Hurria. 2007. <span>“Comprehensive Geriatric Assessment for Older Patients with Cancer.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 25 (14): 1824–31. <a href="https://doi.org/10.1200/JCO.2007.10.6559">https://doi.org/10.1200/JCO.2007.10.6559</a>.
</div>
<div id="ref-facchinetti155" class="csl-entry" role="doc-biblioentry">
Facchinetti, Francesco, Giulia Mazzaschi, Fausto Barbieri, Francesco Passiglia, Francesca Mazzoni, Rossana Berardi, Claudia Proto, et al. 2020. <span>“First-Line Pembrolizumab in Advanced Non-Small Cell Lung Cancer Patients with Poor Performance Status.”</span> <em>European Journal of Cancer (Oxford, England: 1990)</em> 130 (May): 155–67. <a href="https://doi.org/10.1016/j.ejca.2020.02.023">https://doi.org/10.1016/j.ejca.2020.02.023</a>.
</div>
<div id="ref-fuchs2455" class="csl-entry" role="doc-biblioentry">
Fuchs, Georg, Yves R. Chretien, Julia Mario, Synho Do, Matthias Eikermann, Bob Liu, Kai Yang, and Florian J. Fintelmann. 2018. <span>“Quantifying the Effect of Slice Thickness, Intravenous Contrast and Tube Current on Muscle Segmentation: <span>Implications</span> for Body Composition Analysis.”</span> <em>European Radiology</em> 28 (6): 2455–63. <a href="https://doi.org/10.1007/s00330-017-5191-3">https://doi.org/10.1007/s00330-017-5191-3</a>.
</div>
<div id="ref-graffy20190327" class="csl-entry" role="doc-biblioentry">
Graffy, Peter M., Jiamin Liu, Perry J. Pickhardt, Joseph E. Burns, Jianhua Yao, and Ronald M. Summers. 2019. <span>“Deep Learning-Based Muscle Segmentation and Quantification at Abdominal <span>CT</span>: Application to a Longitudinal Adult Screening Cohort for Sarcopenia Assessment.”</span> <em>The British Journal of Radiology</em> 92 (1100): 20190327. <a href="https://doi.org/10.1259/bjr.20190327">https://doi.org/10.1259/bjr.20190327</a>.
</div>
<div id="ref-hemke387" class="csl-entry" role="doc-biblioentry">
Hemke, Robert, Colleen G. Buckless, Andrew Tsao, Benjamin Wang, and Martin Torriani. 2020. <span>“Deep Learning for Automated Segmentation of Pelvic Muscles, Fat, and Bone from <span>CT</span> Studies for Body Composition Assessment.”</span> <em>Skeletal Radiology</em> 49 (3): 387–95. <a href="https://doi.org/10.1007/s00256-019-03289-8">https://doi.org/10.1007/s00256-019-03289-8</a>.
</div>
<div id="ref-hopkins1381" class="csl-entry" role="doc-biblioentry">
Hopkins, Jessica J., Daniel Skubleny, David L. Bigam, Vickie E. Baracos, Dean T. Eurich, and Michael B. Sawyer. 2018. <span>“Barriers to the <span>Interpretation</span> of <span>Body Composition</span> in <span>Colorectal Cancer</span>: <span>A Review</span> of the <span>Methodological Inconsistency</span> and <span>Complexity</span> of the <span>CT-Defined Body Habitus</span>.”</span> <em>Annals of Surgical Oncology</em> 25 (5): 1381–94. <a href="https://doi.org/10.1245/s10434-018-6395-8">https://doi.org/10.1245/s10434-018-6395-8</a>.
</div>
<div id="ref-hurria3826" class="csl-entry" role="doc-biblioentry">
Hurria, Arti, Laura A. Levit, William Dale, Supriya G. Mohile, Hyman B. Muss, Louis Fehrenbacher, Allison Magnuson, et al. 2015. <span>“Improving the <span>Evidence Base</span> for <span>Treating Older Adults With Cancer</span>: <span>American Society</span> of <span>Clinical Oncology Statement</span>.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 33 (32): 3826–33. <a href="https://doi.org/10.1200/JCO.2015.63.0319">https://doi.org/10.1200/JCO.2015.63.0319</a>.
</div>
<div id="ref-iida753" class="csl-entry" role="doc-biblioentry">
Iida, Michihisa, Shigeru Takeda, Chiyo Nakashima, Mitsuo Nishiyama, Yusaku Watanabe, Nobuaki Suzuki, Shigefumi Yoshino, Yuki Nakagami, Tsuyoshi Tanabe, and Hiroaki Nagano. 2022. <span>“Risk Factors for Non-Gastric-Cancer-Related Death After Gastrectomy in Elderly Patients.”</span> <em>Annals of Gastroenterological Surgery</em> 6 (6): 753–66. <a href="https://doi.org/10.1002/ags3.12588">https://doi.org/10.1002/ags3.12588</a>.
</div>
<div id="ref-islame363" class="csl-entry" role="doc-biblioentry">
Islam, S., F. Kanavati, Z. Arain, O. Fadeeva Da Costa, W. Crum, E. O. Aboagye, and A. G. Rockall. 2022. <span>“Fully Automated Deep-Learning Section-Based Muscle Segmentation from <span>CT</span> Images for Sarcopenia Assessment.”</span> <em>Clinical Radiology</em> 77 (5): e363–71. <a href="https://doi.org/10.1016/j.crad.2022.01.036">https://doi.org/10.1016/j.crad.2022.01.036</a>.
</div>
<div id="ref-jack1313a" class="csl-entry" role="doc-biblioentry">
Jack, S., M. A. West, D. Raw, S. Marwood, G. Ambler, T. M. Cope, M. Shrotri, et al. 2014. <span>“The Effect of Neoadjuvant Chemotherapy on Physical Fitness and Survival in Patients Undergoing Oesophagogastric Cancer Surgery.”</span> <em>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</em> 40 (10): 1313–20. <a href="https://doi.org/10.1016/j.ejso.2014.03.010">https://doi.org/10.1016/j.ejso.2014.03.010</a>.
</div>
<div id="ref-jang360" class="csl-entry" role="doc-biblioentry">
Jang, Samuel, Peter M. Graffy, Timothy J. Ziemlewicz, Scott J. Lee, Ronald M. Summers, and Perry J. Pickhardt. 2019. <span>“Opportunistic <span>Osteoporosis Screening</span> at <span>Routine Abdominal</span> and <span>Thoracic CT</span>: <span>Normative L1 Trabecular Attenuation Values</span> in <span>More</span> Than 20 000 <span>Adults</span>.”</span> <em>Radiology</em> 291 (2): 360–67. <a href="https://doi.org/10.1148/radiol.2019181648">https://doi.org/10.1148/radiol.2019181648</a>.
</div>
<div id="ref-kapoore25115" class="csl-entry" role="doc-biblioentry">
Kapoor, Akhil, Vanita Noronha, Vijay M. Patil, Nandini Menon, Amit Joshi, George Abraham, and Kumar Prabhash. 2021. <span>“Immune Checkpoint Inhibitors in Patients with Solid Tumors and Poor Performance Status: <span>A</span> Prospective Data from the Real-World Settings.”</span> <em>Medicine</em> 100 (13): e25115. <a href="https://doi.org/10.1097/MD.0000000000025115">https://doi.org/10.1097/MD.0000000000025115</a>.
</div>
<div id="ref-keating2532" class="csl-entry" role="doc-biblioentry">
Keating, Nancy L., Mary Beth Landrum, Carrie N. Klabunde, Robert H. Fletcher, Selwyn O. Rogers, William R. Doucette, Diana Tisnado, Steven Clauser, and Katherine L. Kahn. 2008. <span>“Adjuvant Chemotherapy for Stage <span>III</span> Colon Cancer: Do Physicians Agree about the Importance of Patient Age and Comorbidity?”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 26 (15): 2532–37. <a href="https://doi.org/10.1200/JCO.2007.15.9434">https://doi.org/10.1200/JCO.2007.15.9434</a>.
</div>
<div id="ref-kemeny786" class="csl-entry" role="doc-biblioentry">
Kemeny, N., and D. W. Braun. 1983. <span>“Prognostic Factors in Advanced Colorectal Carcinoma. <span>Importance</span> of Lactic Dehydrogenase Level, Performance Status, and White Blood Cell Count.”</span> <em>The American Journal of Medicine</em> 74 (5): 786–94. <a href="https://doi.org/10.1016/0002-9343(83)91066-5">https://doi.org/10.1016/0002-9343(83)91066-5</a>.
</div>
<div id="ref-kohne308" class="csl-entry" role="doc-biblioentry">
Köhne, C. H., D. Cunningham, F. Di Costanzo, B. Glimelius, G. Blijham, E. Aranda, W. Scheithauer, et al. 2002. <span>“Clinical Determinants of Survival in Patients with 5-Fluorouracil-Based Treatment for Metastatic Colorectal Cancer: Results of a Multivariate Analysis of 3825 Patients.”</span> <em>Annals of Oncology: Official Journal of the European Society for Medical Oncology</em> 13 (2): 308–17. <a href="https://doi.org/10.1093/annonc/mdf034">https://doi.org/10.1093/annonc/mdf034</a>.
</div>
<div id="ref-koster2520" class="csl-entry" role="doc-biblioentry">
Köster, Johannes, and Sven Rahmann. 2012. <span>“Snakemake–a Scalable Bioinformatics Workflow Engine.”</span> <em>Bioinformatics (Oxford, England)</em> 28 (19): 2520–22. <a href="https://doi.org/10.1093/bioinformatics/bts480">https://doi.org/10.1093/bioinformatics/bts480</a>.
</div>
<div id="ref-krishnane175" class="csl-entry" role="doc-biblioentry">
Krishnan, Mridula, Pooja Kasinath, Robin High, Fang Yu, and Benjamin A. Teply. 2022. <span>“Impact of <span>Performance Status</span> on <span>Response</span> and <span>Survival Among Patients Receiving Checkpoint Inhibitors</span> for <span>Advanced Solid Tumors</span>.”</span> <em>JCO Oncology Practice</em> 18 (1): e175–82. <a href="https://doi.org/10.1200/OP.20.01055">https://doi.org/10.1200/OP.20.01055</a>.
</div>
<div id="ref-kullberg10425" class="csl-entry" role="doc-biblioentry">
Kullberg, Joel, Anders Hedström, John Brandberg, Robin Strand, Lars Johansson, Göran Bergström, and Håkan Ahlström. 2017. <span>“Automated Analysis of Liver Fat, Muscle and Adipose Tissue Distribution from <span>CT</span> Suitable for Large-Scale Studies.”</span> <em>Scientific Reports</em> 7 (1): 10425. <a href="https://doi.org/10.1038/s41598-017-08925-8">https://doi.org/10.1038/s41598-017-08925-8</a>.
</div>
<div id="ref-lavin1536" class="csl-entry" role="doc-biblioentry">
Lavin, P., A. Mittelman, H. Douglass, P. Engstrom, and D. Klaassen. 1980. <span>“Survival and Response to Chemotherapy for Advanced Colorectal Adenocarcinoma: An <span>Eastern Cooperative Oncology Group</span> Report.”</span> <em>Cancer</em> 46 (7): 1536–43. <a href="https://doi.org/10.1002/1097-0142(19801001)46:7<1536::aid-cncr2820460707>3.0.co;2-k">https://doi.org/10.1002/1097-0142(19801001)46:7&lt;1536::aid-cncr2820460707&gt;3.0.co;2-k</a>.
</div>
<div id="ref-lee487" class="csl-entry" role="doc-biblioentry">
Lee, Hyunkwang, Fabian M. Troschel, Shahein Tajmir, Georg Fuchs, Julia Mario, Florian J. Fintelmann, and Synho Do. 2017. <span>“Pixel-<span>Level Deep Segmentation</span>: <span>Artificial Intelligence Quantifies Muscle</span> on <span>Computed Tomography</span> for <span>Body Morphometric Analysis</span>.”</span> <em>Journal of Digital Imaging</em> 30 (4): 487–98. <a href="https://doi.org/10.1007/s10278-017-9988-z">https://doi.org/10.1007/s10278-017-9988-z</a>.
</div>
<div id="ref-lenchik277" class="csl-entry" role="doc-biblioentry">
Lenchik, Leon, Ryan Barnard, Robert D. Boutin, Stephen B. Kritchevsky, Haiying Chen, Josh Tan, Peggy M. Cawthon, Ashley A. Weaver, and Fang-Chi Hsu. 2021. <span>“Automated <span>Muscle Measurement</span> on <span>Chest CT Predicts All-Cause Mortality</span> in <span>Older Adults From</span> the <span>National Lung Screening Trial</span>.”</span> <em>The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences</em> 76 (2): 277–85. <a href="https://doi.org/10.1093/gerona/glaa141">https://doi.org/10.1093/gerona/glaa141</a>.
</div>
<div id="ref-lenchik1695" class="csl-entry" role="doc-biblioentry">
Lenchik, Leon, Laura Heacock, Ashley A. Weaver, Robert D. Boutin, Tessa S. Cook, Jason Itri, Christopher G. Filippi, et al. 2019. <span>“Automated <span>Segmentation</span> of <span>Tissues Using CT</span> and <span>MRI</span>: <span>A Systematic Review</span>.”</span> <em>Academic Radiology</em> 26 (12): 1695–1706. <a href="https://doi.org/10.1016/j.acra.2019.07.006">https://doi.org/10.1016/j.acra.2019.07.006</a>.
</div>
<div id="ref-lyu839516" class="csl-entry" role="doc-biblioentry">
Lyu, Jiahua, Anhui Shi, Tao Li, Jie Li, Ren Zhao, Shuchai Zhu, Jianhua Wang, et al. 2022. <span>“Effects of <span>Enteral Nutrition</span> on <span>Patients With Oesophageal Carcinoma Treated With Concurrent Chemoradiotherapy</span>: <span>A Prospective</span>, <span>Multicentre</span>, <span>Randomised</span>, <span>Controlled Study</span>.”</span> <em>Frontiers in Oncology</em> 12: 839516. <a href="https://doi.org/10.3389/fonc.2022.839516">https://doi.org/10.3389/fonc.2022.839516</a>.
</div>
<div id="ref-martin227" class="csl-entry" role="doc-biblioentry">
Martin, Lisa, Ioannis Gioulbasanis, Pierre Senesse, and Vickie E. Baracos. 2020. <span>“Cancer-<span>Associated Malnutrition</span> and <span>CT-Defined Sarcopenia</span> and <span>Myosteatosis Are Endemic</span> in <span>Overweight</span> and <span>Obese Patients</span>.”</span> <em>JPEN. Journal of Parenteral and Enteral Nutrition</em> 44 (2): 227–38. <a href="https://doi.org/10.1002/jpen.1597">https://doi.org/10.1002/jpen.1597</a>.
</div>
<div id="ref-mohile2326" class="csl-entry" role="doc-biblioentry">
Mohile, Supriya G., William Dale, Mark R. Somerfield, Mara A. Schonberg, Cynthia M. Boyd, Peggy S. Burhenn, Beverly Canin, et al. 2018. <span>“Practical <span>Assessment</span> and <span>Management</span> of <span>Vulnerabilities</span> in <span>Older Patients Receiving Chemotherapy</span>: <span>ASCO Guideline</span> for <span>Geriatric Oncology</span>.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 36 (22): 2326–47. <a href="https://doi.org/10.1200/JCO.2018.78.8687">https://doi.org/10.1200/JCO.2018.78.8687</a>.
</div>
<div id="ref-morsbach50" class="csl-entry" role="doc-biblioentry">
Morsbach, Fabian, Yi-Hua Zhang, Lena Martin, Catarina Lindqvist, and Torkel Brismar. 2019. <span>“Body Composition Evaluation with Computed Tomography: <span>Contrast</span> Media and Slice Thickness Cause Methodological Errors.”</span> <em>Nutrition (Burbank, Los Angeles County, Calif.)</em> 59 (March): 50–55. <a href="https://doi.org/10.1016/j.nut.2018.08.001">https://doi.org/10.1016/j.nut.2018.08.001</a>.
</div>
<div id="ref-perez-de-acha1377" class="csl-entry" role="doc-biblioentry">
Perez-de-Acha, Andrea, Sophie Pilleron, and Enrique Soto-Perez-de-Celis. 2022. <span>“All-<span>Cause Mortality Risk Prediction</span> in <span>Older Adults</span> with <span>Cancer</span>: <span>Practical Approaches</span> and <span>Limitations</span>.”</span> <em>Current Oncology Reports</em> 24 (11): 1377–85. <a href="https://doi.org/10.1007/s11912-022-01303-2">https://doi.org/10.1007/s11912-022-01303-2</a>.
</div>
<div id="ref-perthen142" class="csl-entry" role="doc-biblioentry">
Perthen, Joanna E., Tamir Ali, David McCulloch, Maziar Navidi, Alexander W. Phillips, Rhona C. F. Sinclair, S. Michael Griffin, Alastair Greystoke, and George Petrides. 2018. <span>“Intra- and Interobserver Variability in Skeletal Muscle Measurements Using Computed Tomography Images.”</span> <em>European Journal of Radiology</em> 109 (December): 142–46. <a href="https://doi.org/10.1016/j.ejrad.2018.10.031">https://doi.org/10.1016/j.ejrad.2018.10.031</a>.
</div>
<div id="ref-petrillo2288" class="csl-entry" role="doc-biblioentry">
Petrillo, Laura A., Areej El-Jawahri, Ryan D. Nipp, Morgan R. L. Lichtenstein, Sienna M. Durbin, Kerry L. Reynolds, Joseph A. Greer, Jennifer S. Temel, and Justin F. Gainor. 2020. <span>“Performance Status and End-of-Life Care Among Adults with Nonsmall Cell Lung Cancer Receiving Immune Checkpoint Inhibitors.”</span> <em>Cancer</em> 126 (10): 2288–95. <a href="https://doi.org/10.1002/cncr.32782">https://doi.org/10.1002/cncr.32782</a>.
</div>
<div id="ref-popuri512" class="csl-entry" role="doc-biblioentry">
Popuri, Karteek, Dana Cobzas, Nina Esfandiari, Vickie Baracos, and Martin Jägersand. 2016. <span>“Body <span>Composition Assessment</span> in <span>Axial CT Images Using FEM-Based Automatic Segmentation</span> of <span>Skeletal Muscle</span>.”</span> <em>IEEE Transactions on Medical Imaging</em> 35 (2): 512–20. <a href="https://doi.org/10.1109/TMI.2015.2479252">https://doi.org/10.1109/TMI.2015.2479252</a>.
</div>
<div id="ref-rosati578" class="csl-entry" role="doc-biblioentry">
Rosati, Gerardo, Stefano Cordio, Giorgio Reggiardo, Giuseppe Aprile, Alfredo Butera, Antonio Avallone, Aniello Tucci, et al. 2019. <span>“Oxaliplatin-<span>Based Chemotherapy</span> in <span>Patients</span> with <span>Metastatic Colorectal Cancer Aged</span> at <span>Least</span> 75 <span>Years</span>: <span>A Post-Hoc Subgroup Analysis</span> of <span>Three Phase II Trials</span>.”</span> <em>Cancers</em> 11 (4): 578. <a href="https://doi.org/10.3390/cancers11040578">https://doi.org/10.3390/cancers11040578</a>.
</div>
<div id="ref-ruden2918" class="csl-entry" role="doc-biblioentry">
Ruden, Emily, David A. Reardon, April D. Coan, James E. Herndon, Whitney E. Hornsby, Miranda West, Diane R. Fels, et al. 2011. <span>“Exercise Behavior, Functional Capacity, and Survival in Adults with Malignant Recurrent Glioma.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 29 (21): 2918–23. <a href="https://doi.org/10.1200/JCO.2011.34.9852">https://doi.org/10.1200/JCO.2011.34.9852</a>.
</div>
<div id="ref-sargent1948" class="csl-entry" role="doc-biblioentry">
Sargent, Daniel J., Claus Henning Köhne, Hanna Kelly Sanoff, Brian M. Bot, Matthew T. Seymour, Aimery de Gramont, Ranier Porschen, et al. 2009. <span>“Pooled <span>Safety</span> and <span>Efficacy Analysis Examining</span> the <span>Effect</span> of <span>Performance Status</span> on <span>Outcomes</span> in <span>Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer</span>.”</span> <em>Journal of Clinical Oncology</em> 27 (12): 1948–55. <a href="https://doi.org/10.1200/JCO.2008.20.2879">https://doi.org/10.1200/JCO.2008.20.2879</a>.
</div>
<div id="ref-schnipper10" class="csl-entry" role="doc-biblioentry">
Schnipper, Lowell E, Thomas J Smith, Derek Raghavan, Douglas W Blayney, Patricia A Ganz, Therese Marie Mulvey, and Dana S Wollins. n.d. <span>“American <span>Society</span> of <span>Clinical Oncology Identifies Five Key Opportunities</span> to <span>Improve Care</span> and <span>Reduce Costs</span>: <span>The Top Five List</span> for <span>Oncology</span>.”</span> <em>JOURNAL OF CLINICAL ONCOLOGY</em>, 10.
</div>
<div id="ref-simmonds531" class="csl-entry" role="doc-biblioentry">
Simmonds, P. C. 2000. <span>“Palliative Chemotherapy for Advanced Colorectal Cancer: Systematic Review and Meta-Analysis. <span>Colorectal Cancer Collaborative Group</span>.”</span> <em>BMJ (Clinical Research Ed.)</em> 321 (7260): 531–35. <a href="https://doi.org/10.1136/bmj.321.7260.531">https://doi.org/10.1136/bmj.321.7260.531</a>.
</div>
<div id="ref-soto-perez-de-celise305" class="csl-entry" role="doc-biblioentry">
Soto-Perez-de-Celis, Enrique, Daneng Li, Yuan Yuan, Yat Ming Lau, and Arti Hurria. 2018. <span>“Functional Versus Chronological Age: Geriatric Assessments to Guide Decision Making in Older Patients with Cancer.”</span> <em>The Lancet. Oncology</em> 19 (6): e305–16. <a href="https://doi.org/10.1016/S1470-2045(18)30348-6">https://doi.org/10.1016/S1470-2045(18)30348-6</a>.
</div>
<div id="ref-vanderwerf366" class="csl-entry" role="doc-biblioentry">
van der Werf, Anne, Ingeborg M. Dekker, Martijn R. Meijerink, Nicolette J. Wierdsma, Marian A. E. de van der Schueren, and Jacqueline A. E. Langius. 2018. <span>“Skeletal Muscle Analyses: Agreement Between Non-Contrast and Contrast <span>CT</span> Scan Measurements of Skeletal Muscle Area and Mean Muscle Attenuation.”</span> <em>Clinical Physiology and Functional Imaging</em> 38 (3): 366–72. <a href="https://doi.org/10.1111/cpf.12422">https://doi.org/10.1111/cpf.12422</a>.
</div>
<div id="ref-vanvugt1707" class="csl-entry" role="doc-biblioentry">
van Vugt, Jeroen L. A., Robert R. J. Coebergh van den Braak, Henk J. W. Schippers, Kevin M. Veen, Stef Levolger, Ron W. F. de Bruin, Marcel Koek, Wiro J. Niessen, Jan N. M. IJzermans, and François E. J. A. Willemsen. 2018. <span>“Contrast-Enhancement Influences Skeletal Muscle Density, but Not Skeletal Muscle Mass, Measurements on Computed Tomography.”</span> <em>Clinical Nutrition (Edinburgh, Scotland)</em> 37 (5): 1707–14. <a href="https://doi.org/10.1016/j.clnu.2017.07.007">https://doi.org/10.1016/j.clnu.2017.07.007</a>.
</div>
<div id="ref-verduzco-aguirre68" class="csl-entry" role="doc-biblioentry">
Verduzco-Aguirre, Haydee Cristina, Carolina Gomez-Moreno, Yanin Chavarri-Guerra, and Enrique Soto-Perez-de-Celis. 2019. <span>“Predicting <span>Life Expectancy</span> for <span>Older Adults</span> with <span>Cancer</span> in <span>Clinical Practice</span>: <span>Implications</span> for <span class="nocase">Shared Decision-making</span>.”</span> <em>Current Oncology Reports</em> 21 (8): 68. <a href="https://doi.org/10.1007/s11912-019-0821-3">https://doi.org/10.1007/s11912-019-0821-3</a>.
</div>
<div id="ref-wong385" class="csl-entry" role="doc-biblioentry">
Wong, Annie, Molly Williams, Donna Milne, Kortnye Morris, Peter Lau, Odette Spruyt, Sonia Fullerton, and Grant McArthur. 2017. <span>“Clinical and Palliative Care Outcomes for Patients of Poor Performance Status Treated with Antiprogrammed Death-1 Monoclonal Antibodies for Advanced Melanoma.”</span> <em>Asia-Pacific Journal of Clinical Oncology</em> 13 (6): 385–90. <a href="https://doi.org/10.1111/ajco.12702">https://doi.org/10.1111/ajco.12702</a>.
</div>
<div id="ref-yange2012534" class="csl-entry" role="doc-biblioentry">
Yang, Fang, Svetomir N. Markovic, Julian R. Molina, Thorvardur R. Halfdanarson, Lance C. Pagliaro, Ashish V. Chintakuntlawar, Rutian Li, et al. 2020. <span>“Association of <span>Sex</span>, <span>Age</span>, and <span>Eastern Cooperative Oncology Group Performance Status With Survival Benefit</span> of <span>Cancer Immunotherapy</span> in <span>Randomized Clinical Trials</span>: <span>A Systematic Review</span> and <span class="nocase">Meta-analysis</span>.”</span> <em>JAMA Network Open</em> 3 (8): e2012534. <a href="https://doi.org/10.1001/jamanetworkopen.2020.12534">https://doi.org/10.1001/jamanetworkopen.2020.12534</a>.
</div>
</div></section></div></main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    target: function(trigger) {
      return trigger.previousElementSibling;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    setTimeout(function() {
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const cites = ref.parentNode.getAttribute('data-cites').split(' ');
    tippyHover(ref, function() {
      var popup = window.document.createElement('div');
      cites.forEach(function(cite) {
        var citeDiv = window.document.createElement('div');
        citeDiv.classList.add('hanging-indent');
        citeDiv.classList.add('csl-entry');
        var biblioDiv = window.document.getElementById('ref-' + cite);
        if (biblioDiv) {
          citeDiv.innerHTML = biblioDiv.innerHTML;
        }
        popup.appendChild(citeDiv);
      });
      return popup.innerHTML;
    });
  }
});
</script>
</div> <!-- /content -->



</body></html>